Comparisons of haplo-identical SCT using the Chinese approach combining T replete G-CSF mobilized bone marrow stem cell graft, a myeloablative conditioning regimen with ATG, to matched related and unrelated allo-SCT for acute leukemias have shown equivalent OS with reduced risk of relapse in high-risk leukemias in the haplo-identical groups [34, 35]. The gene discussed is CSF3; the disease is acute leukemia.